track 3 - patients and advocates as entrepreneurs: new models for drug development
Published 4 years ago • 22 plays • Length 1:05:12Download video MP4
Download video MP3
Similar videos
-
1:02:23
track 3 - early drug development what patients bring
-
50:32
track 3: patients as investors
-
43:31
day 1 - track 4 - 3:40 p.m. - new models for drug discovery
-
59:23
rare drug development symposium: developing legal agreements in research collaborations
-
51:46
patient advocacy track preclinical modeling – what advocates need to know about animal & cell models
-
52:31
track 3: laying the foundation the role and goals of discovery and preclinical research
-
1:01:26
track 2: the promise and perils of working with industry lessons from avocacy group experience on a
-
58:33
2013 drug development 101
-
1:17:30
a new era of medicine with ips cells - lecture by professor shinya yamanaka
-
55:24
challenges in drug development for als
-
1:04:43
future of health care raveen kariyawasam [08/09/2022]
-
51:40
patient advocacy track – building a research strategy roadmap for your organization
-
1:02:51
track 4 - technologies for learning about rare disease from patients and caregivers
-
48:02
track 3: the drug re discovery pipline finding new indications for approved therapeutics
-
56:19
track 3: show your data what do you need to have before approaching industry
-
48:00
track 3 2 30 clinical trial training pre drug deveopment
-
48:00
track 3 2 30 clinical trial training pre drug deveopment